Next |
home / stock / inmb / inmb message board
Subject | By | Source | When |
---|---|---|---|
Did the trial in ovarian ever start? | jondoeuk | investorshub | 04/11/2023 7:45:58 PM |
Don't need to convince us. We are fully | derkampfer | investorshub | 04/09/2023 1:10:54 PM |
Sure, it is early days in patients, but | jondoeuk | investorshub | 04/06/2023 11:10:04 PM |
blocked | dennisdave | investorshub | 12/01/2022 3:05:20 PM |
INMB chart....finally a reversal? | conix | investorshub | 03/30/2022 1:11:42 AM |
$INMB Chart | conix | investorshub | 09/21/2021 5:21:04 PM |
XPro news also impressive. Data very. The data | derkampfer | investorshub | 09/02/2021 12:10:24 PM |
INKmune news was impressive. Albeit one patient dosed | derkampfer | investorshub | 08/26/2021 3:45:08 PM |
Almost, $13 to $10 is a downward slope. | spartex | investorshub | 05/09/2021 12:03:21 AM |
Booooooom? More like, BurP! LOL. Still | spartex | investorshub | 05/08/2021 11:59:16 PM |
New run began today. Deeper dive Alzheimers drug | derkampfer | investorshub | 04/17/2021 2:27:32 AM |
$INMB just ran from $2.00 to 30.00 congrats | Fress | investorshub | 01/21/2021 12:56:46 PM |
I need a bigger rake to scoop up | john sezso | investorshub | 01/06/2021 9:58:37 PM |
Still crickets here.... | john sezso | investorshub | 01/06/2021 1:59:36 AM |
Good enough for Harry Reid it's good enough | john sezso | investorshub | 12/31/2020 2:46:09 PM |
They are speaking with Roth Capital right now | byrdiesoccer | investorshub | 10/28/2020 1:13:41 PM |
Shorts bring this to 8 I wanna buy | akamaii | investorshub | 10/17/2020 2:35:47 PM |
$INMB CHART >>>> going in position before test | l2 hunter | investorshub | 07/21/2020 3:48:27 PM |
Wow that public offering is peanuts ...Kaboom here tomorrow | starkd748 | investorshub | 07/20/2020 10:25:45 PM |
znewcar1: INMB 26% v1,8M c14.08 f10,9M H14.74 looking strong aft hours | znewcar1 | investorshangout | 07/20/2020 10:21:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
Boca Raton, Florida, April 30, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is pleased to share an up...
Boca Raton, Florida, April 29, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, continues to advance its Nat...